Abstract
Amniotic fluid embolism is one of the most devastating complications in obstetrics. Intensivists are often called upon to co-manage cases of suspected amniotic fluid embolism with our colleagues in obstetrics and anesthesia, so familiarity with this condition is essential. Amniotic fluid embolism is characterized by the sudden onset of hypotension, hypoxia, and coagulopathy during, or immediately after, delivery. Although rare in an absolute sense, amniotic fluid embolism is identified as the leading cause of maternal mortality in many developed countries. Amniotic fluid embolism is thought to occur when amniotic fluid enters into the maternal systemic circulation through a breach in the maternal–fetal interface, leading to the release of inflammatory mediators and endogenous catecholamines that cause acute cor pulmonale and severe disseminated intravascular coagulation (DIC). The diagnosis of amniotic fluid embolism is a clinical diagnosis of exclusion; there is no gold-standard test or biomarker. The treatment is largely supportive. Despite prior reports of mortality rates exceeding 80%, current evidence supports a mortality rate of approximately 20%.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McDonnell N, Knight M, Peek MJ, et al. Amniotic fluid embolism: an Australian-New Zealand population-based study. BMC Pregn Childb. 2015;15:352.
Clark SL. Amniotic fluid embolism. Obstet Gynecol. 2014;123:337–48.
Funk M, Damron A, Bandi V, Aagaard K, Szigeti R, Clark S. Pulmonary vascular obstruction by squamous cells is not involved in amniotic fluid embolism. Am J Obstet Gynecol. 2018;218:460–1.
Sultan P, Seligman K, Carvalho B. Amniotic fluid embolism: update and review. Curr Opin Anaesthesiol. 2016;29:288–96.
Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol. 2009;201:445.e1–13.
Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol. 2008;199:49.e1–8.
Simard C, Yang S, Koolian M, Shear R, Rudski L, Lipes J. The role of echocardiography in amniotic fluid embolism: a case series and review of the literature. Can J Anaesth. 2021;68:1541–8.
Benson MD. A hypothesis regarding complement activation and amniotic fluid embolism. Med Hypotheses. 2007;68:1019–25.
Collins NF, Bloor M, McDonnell NJ. Hyperfibrinolysis diagnosed by rotational thromboelastometry in a case of suspected amniotic fluid embolism. Int J Obstet Anesth. 2013;22:71–6.
Fudaba M, Tachibana D, Misugi T, Nakano A, Koyama M. Excessive fibrinolysis detected with thromboelastography in a case of amniotic fluid embolism: fibrinolysis may precede coagulopathy. J Thromb Thrombolysis. 2021;51:818–20.
Loughran JA, Kitchen TL, Sindhakar S, Ashraf M, Awad M, Kealaher EJ. Rotational thromboelastometry (ROTEM®)-guided diagnosis and management of amniotic fluid embolism. Int J Obstet Anesth. 2019;38:127–30.
Benson MD. Amniotic fluid embolism mortality rate. J Obstet Gynaecol Res. 2017;43:1714–8.
Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 1995;172:1158–67.
Lee W, Ginsburg KA, Cotton DB, Kaufman RH. Squamous and trophoblastic cells in the maternal pulmonary circulation identified by invasive hemodynamic monitoring during the peripartum period. Am J Obstet Gynecol. 1986;155:999–1001.
Bouvet L, Gariel C, Charvet A, Boisson-Gaudin C, Chassard D. Contribution of blood detection of insulin-like growth factor binding protein-1 for the diagnosis of amniotic-fluid embolism: a retrospective multicentre cohort study. BJOG. 2021;128:1966–73.
Clark SL, Romero R, Dildy GA, et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 2016;215:408–12.
Toppozada H, Michaels L, Toppozada M, El-Ghazzawi I, Talaat M, Elwany S. The human respiratory nasal mucosa in pregnancy. An electron microscopic and histochemical study. J Laryngol Otol. 1982;96:613–26.
Aissi James S, Klein T, Lebreton G, et al. Amniotic fluid embolism rescued by venoarterial extracorporeal membrane oxygenation. Crit Care. 2022;26:96.
Wothe JK, Elfstrand E, Mooney MR, Wothe DD. Rotational thromboelastometry-guided venoarterial extracorporeal membrane oxygenation in the treatment of amniotic fluid embolism. Case Rep Obstet Gynecol. 2022;2022:9658708.
Gitman R, Bachar B, Mendenhall B. Amniotic fluid embolism treated with veno-arterial extracorporeal membrane oxygenation. Case Rep Crit Care. 2019;2019:4589636.
Viau-Lapointe J, Filewod N. Extracorporeal therapies for amniotic fluid embolism. Obstet Gynecol. 2019;134:989–94.
Adachi M, Adachi T, Fujita T, Hyuga S, Onishi Y, Okutomi T. Venoarterial extracorporeal membrane oxygenation as an early treatment for amniotic fluid embolism with cardiac arrest: a case report. J Obstet Gynaecol Res. 2021;47:3374–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
LaFond, E., Bakker, J. (2023). Amniotic Fluid Embolism. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2023. Annual Update in Intensive Care and Emergency Medicine. Springer, Cham. https://doi.org/10.1007/978-3-031-23005-9_36
Download citation
DOI: https://doi.org/10.1007/978-3-031-23005-9_36
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-23004-2
Online ISBN: 978-3-031-23005-9
eBook Packages: MedicineMedicine (R0)